Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a woman with total-body hair loss grow her hair back.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

JAK inhibitors are effective treatments for alopecia areata.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.